Quantitative modeling of the high-throughput production and in vivo kinetics of (drug-encapsulating) liposomes.
In developing liposomes for in vivo use, it is important to design the liposomes to have optimal in vivo kinetics, and it is also necessary to identify optimal high-throughput production conditions for these liposomes. Previous work has not definitively established the general relationship between liposomes' configuration and composition, and their in vivo kinetics. Also, no straightforward method exists to calculate optimal liposome high-throughput production conditions for specific liposome compositions. This work presents first-principles quantitative correlations describing liposomes' in vivo drug leakage and vascular mass transfer kinetics. This work further presents a simple quantitative model relating specific liposome compositions to ideal high-throughput production parameters. The results have implications for the identification of promising liposome compositions via high-throughput screening methodologies, as well as the design and optimization of high-throughput reactors for liposome production.
Wong
Albert
A
Yale University, New Haven, Connecticut, United States of America. albert.wong@yale.edu
D004337:Drug Carriers / Q000737:chemistry*; D005119:Extravasation of Diagnostic and Therapeutic Materials; D007700:Kinetics; D008081:Liposomes / Q000138:chemical synthesis / Q000737:chemistry / Q000627:therapeutic use*; D010539:Permeability; D010599:Pharmacokinetics
D004337:Drug Carriers; D008081:Liposomes